Unique ID issued by UMIN | UMIN000014336 |
---|---|
Receipt number | R000016680 |
Scientific Title | The feasibility and safety study of the central nervous functional recovery therapy using a wearable human support robot HAL for the patients with the central motor dysfunction. |
Date of disclosure of the study information | 2014/07/01 |
Last modified on | 2016/09/28 21:58:23 |
The feasibility and safety study of the central nervous functional recovery therapy using a wearable human support robot HAL for the patients with the central motor dysfunction.
The feasibility and safety study of the functional recovery therapy using a robot suit HAL for the central motor dysfunction.
The feasibility and safety study of the central nervous functional recovery therapy using a wearable human support robot HAL for the patients with the central motor dysfunction.
The feasibility and safety study of the functional recovery therapy using a robot suit HAL for the central motor dysfunction.
Japan |
The central moter dysfunction associated with stroke, cerebrospinal injury, cerebrospinal tumor and neuromusclar disease
Neurology | Orthopedics | Neurosurgery |
Emergency medicine | Rehabilitation medicine |
Others
NO
To verify the safety and feasibility of clinical trials to evaluate the promotion of improvement in central motor dysfuction by performing the treatment of functional recovery using HAL in the acute phase.
Safety
1. Adverse event
2. Failure of HAL and ancillary equipment
3. Feasibility of study protocol
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Treatment
Device,equipment |
The treatment of functional recovery using HAL for single joint or HAL for lower limb, about 2 times for a week.
16 | years-old | <= |
Not applicable |
Male and Female
1. Patients can consent by a document. If the handwriting is difficult due to the primary disease, it is assumed to obtain a document consent from ghost-writing user.
2. Patients 16 years of age or older. The consent of the legal representative's is needed for the patients of minors 16-20 years of age.
3. Patients who are hospitalized in the general ward, ICU or HCU.
4. Patients can wear HAL, weighing 40-100 kg, height is 150-190 cm.
5. Patients who can be hospitalized continuously along the test schedule.
1. It is difficult to perform the volantary movement of the limbs in accordance with the instructions due to the disturbance of consciousness or dementia.
2. It is difficult to wear HAL or train using HAL due to the severe deformation of the skeletal system.
3. Patients has a complication, which can disturb the treatment using HAL.
4. The biological edectrode for HAL can not be affixed to patient's skin due to the skin disease.
15
1st name | |
Middle name | |
Last name | Akira Matsumura |
Faculty of Medicine, University of Tsukuba
Division of Clinical Medicine, Department of Neurosurgery
1-1-1 Tennodai Tsukuba, Ibaraki Japan
029-853-3220
a-matsumur@md.tsukuba.ac.jp
1st name | |
Middle name | |
Last name | Aiki Marushima |
Faculty of Medicine, University of Tsukuba
Division of Clinical Medicine, Department of Neurosurgery, Emergency and Critical Care Medicine
1-1-1 Tennodai Tsukuba, Ibaraki Japan
029-853-3220
aiki.marushima@md.tsukuba.ac.jp
University of Tsukuba
University of Tsukuba
Other
NO
筑波大学附属病院(茨城県)
2014 | Year | 07 | Month | 01 | Day |
Unpublished
Enrolling by invitation
2014 | Year | 06 | Month | 23 | Day |
2014 | Year | 07 | Month | 14 | Day |
2014 | Year | 06 | Month | 21 | Day |
2016 | Year | 09 | Month | 28 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000016680